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African trypanosomiasis encompasses diseases caused by pathogenic trypanosomes, infecting both humans
and animals. In the present article, we dissected the possible role of members of the interleukin (IL)–12 family
during infection with Trypanosoma brucei brucei and Trypanosoma evansi in mice. IL-12p35/, IL-12p40/,
and IL-12p35//p40/ mice were susceptible to both pathogens, as was demonstrated by the increased mor-
tality among these mice, compared with wild-type C57BL/6 mice. The different IL-12p70/ mouse strains
showed similar mortality kinetics, suggesting that IL-12p70—but not the IL-12p80 homodimer or IL-23—
plays a crucial role in survival. Although there were similar plasma levels of immunoglobulin (Ig) M and
IgG2a in IL-12–deficient mice and wild-type mice, interferon (IFN)–g production, especially during early
infection, was severely impaired in all IL-12p70/ mouse strains, demonstrating an IL-12p70–dependent
mechanism for IFN-g production. Because IFN-g receptor–deficient mice (IFN-gR/) were also highly sus-
ceptible to both Trypanosoma species, IL-12p70–dependent IFN-g production seems to be the important
mechanism involved in resistance against both pathogens.
Trypanosomes are unicellular eukaryotic parasites that
replicate freely in the bloodstream of a mammalian
host, ultimately resulting in sleeping sickness in hu-
mans, “nagana” (due to Trypanosoma brucei brucei) in
cattle, or “surra” (due to Trypanosoma evansi) in var-
ious other animals [1].
Trypanosomes regulate and escape the B and T cell
responses of the host. The foremost mechanism is an-
tigenic variation, whereby the surface coat of the try-
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panosome consisting of variant surface glycoprotein
(VSG) is regularly replaced, thus continually evading
the immune response of the host [2, 3]. At the time of
infection, the host responds with rapid B cell activation,
which has been found to be important for clearance of
parasites from within vascular regions [4, 5]. Further-
more, a rapid Th1 response is initiated [6–9], with the
characteristic production of interleukin (IL)–12 and in-
terferon (IFN)–g [10]. Results from Mansfield and
Paulnock [11] suggested that initiation of a polarized
VSG-specific Th1 cellular response is dependent on the
presence of IL-12 and IL-18.
The IL-12p70 molecule is a heterodimeric protein
composed of 2 glycosylated subunits—namely, p35 and
p40 [12, 13]. The p40 subunits also form homodimers
(i.e., IL-12p80) and may act antagonistically to the
functioning of IL-12 by blocking signal transduction
via the receptor [14]. However, IL-12p80 homodimer
may also act in an agonistic manner to IL-12 in its
ability to induce cell-mediated Th1 immune responses
[15, 16]. In addition to forming p35/p40 and p80 di-
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IL-23 [17]. The IL-12p80 homodimer also acts as an antagonist
in IL-23 signaling [14].
Studies using IL-12–deficient mice in models of severe in-
fectious disease, such as toxoplasmosis [18], listeriosis [19],
leishmaniasis [20], Chagas disease [21], and tuberculosis [16],
have found that IL-12–independent IFN-g can be produced,
resulting in residual resistance. IFN-g, which plays a central
role in resistance to trypanosomiasis, is produced primarily by
activated Th1 cells, which, in turn, induce macrophages to
release trypanocidal molecules, including reactive oxygen in-
termediates, reactive nitrogen intermediates, and tumor necro-
sis factor (TNF) [7, 8, 22, 23]. Mice lacking TNF have displayed
reduced ability to control the parasite load in the vascular com-
partment [24].
In this comparative study of T. b. brucei and T. evansi in-
fection models, the IL-12 family—namely, IL-12p70, IL-12p80
homodimer, and IL-23—were examined using IL-12p35–, IL-
12p40–, and IL-12p35/p40–deficient mice. The data obtained
suggest that IL-12p70—but not IL-12p80 homodimer or IL-
23—is necessary for the development of resistance against both
T. brucei and T. evansi parasites. IL-12 deletion resulted in the
impaired IFN-g production necessary for parasitemia control
and survival.
MATERIALS AND METHODS
Mice. IL-12p35/ [20] and IL-12p40/ [25] on a 129Sv/Ev
background, backcrossed 5 times to C57BL/6, IFN-g receptor
(IFN-gR)/ 129Sv/Ev [26], C57BL/6, and 129Sv/Ev mice were
maintained under specific pathogen–free conditions. For the
generation of homozygous double-deficient mice, IL-12p35/
and IL-12p40/ mice were intercrossed and genotyped by poly-
merase chain reaction [20, 25]. Experiments were performed
within the guidelines of the Animal Research Ethics Board of
the University of Cape Town (Cape Town, South Africa) (an-
imal ethics approval number 005/041).
Parasites. The pleomorphic T. b. brucei AnTat 1.1E clone
and T. evansi (code, KETRI 2480; stock no., ITMAS 110297)
were obtained from the Institute of Tropical Medicine (An-
twerp, Belgium).
Infection and parasitemia. Mice were infected intraperi-
toneally with T. b. brucei trypanosomes and T.3 35 10 1 10
evansi trypanosomes. Blood samples were obtained for parasite
enumeration, diluted 1/200 in RPMI 1640 (10% fetal calf se-
rum) (Highveld Biological, Johannesburg), and counted under
a light microscope (Nikon).
Cytokine ELISAs. Cytokines in plasma were measured by
ELISA performed as described elsewhere [27], with modifica-
tions. Plasma and cytokine standards were serially diluted 3-
and 2-fold, respectively. Cytokine standards, together with coat-
ing and biotinylated antibodies for TNF and IFN-g (BD
PharMingen), were used. Streptavidin-labeled horseradish per-
oxidase (BD PharMingen) and 3,3′,5,5-tetramethylbenzidine
(KPL) were used for detection and development, respectively.
The lower limit of detection for both IFN-g and TNF was 16
pg/mL.
Quantification of anti-VSG plasma titers. Anti–trypano-
some-derived antigen antibody titers were determined as de-
scribed elsewhere [28].
Graph and statistical analysis. Data are expressed as the
mean (SE) of individual determinations, with statistical
analysis performed using the unpaired Student’s t test for ELI-
SAs. Survival data showed that, for each experiment, mortality
in 11 IL-12–deficient group was significantly increased, com-
pared with mortality in wild-type mice, by use of Kaplan-Meier
analysis with the log-rank test. Thus, experiments were pooled,
increasing the number of mice per group. Analysis between
wild-type groups of repeated experiments performed using 1-
way analysis of variance (ANOVA), with Dunnett’s test per-
formed as the posttest, found that parasitemia was not signif-
icantly different between experiments, and, thus, data were
pooled. At each time point, the pooled parasitemia was analyzed
using 1-way ANOVA, with Dunnett’s test performed as a post-
test and Student’s t test performed to compare IL-12– and IFN-
gR–deficient mice with their wild-type controls, respectively.
RESULTS
Reduced survival among IL-12p355/5/p405/5, IL-12p405/5,
and IL-12p355/5 mice infected with T. b. brucei and T.
evansi. To determine the role of IL-12p70 (p35/p40), IL-23
(p19/p40), and IL-12p80 homodimer during trypanosomiasis,
mice deficient in either the p35 gene, the p40 gene, or both
were infected with T. b. brucei and T. evansi and were monitored
for survival (table 1). The duration of survival was significantly
decreased in all T. b. brucei– and T. evansi–infected mice de-
ficient in the p35 gene, the p40 gene, or both, compared with
survival among infected wild-type controls. No differences in
mortality were observed between the different groups of IL-
12–deficient mice.
A specific role for IL-12 in the control of parasitemia in
T. b. brucei–infected mice during the chronic stages of disease.
The first parasitemia peak (occurring 5–8 days after infection,
depending on the Trypanosoma strain) was similar in all 3 p35-
and p40-deficient mice infected with T. b. brucei or T. evansi
and in wild-type controls (figure 1A and 1B). However, the
rate of clearance of the first parasitemia peak was slightly re-
duced (by 4- to 8-fold) in IL-12–deficient mice, compared with
wild-type mice infected with T. b. brucei, at day 7 after infection
( ) (figure 1A).P ! .05
The second parasitemia peak and subsequent parasite control
were clearly impaired during T. b. brucei infection, with an up
to 100-fold increase in the parasite burden occurring in IL-12–
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Table 1. Increased mortality among interleukin (IL)–12–deficient
mice infected with Trypanosoma brucei brucei or Trypanosoma








Wild type 40.6  8.8 29
IL-12p35//p40/ 35.1  6.4 15 !.05
IL-12p40/ 32.0  3.7 15 !.0001
IL-12p35/ 33.3  4.2 15 !.001
T. evansi
Wild type 47.0  24.1 33
IL-12p35//p40/ 31.4  14.3 35 !.001
IL-12p405/5 31.1  13.1 21 !.001
IL-12p35/ 30.3  20.6 34 !.01
a Mice were intraperitoneally infected with 5  103 T. b. brucei try-3510
panosomes and T. evansi trypanosomes and were monitored daily for3110
survival.
b Results from 3 independent experiments were combined.
c Compared with wild-type mice. Statistical significance was determined
using the Kaplan-Meier test.
Figure 1. Parasitemia profiles of Trypanosoma brucei brucei–infected
(A) and Trypanosoma evansi–infected (B) wild-type (), interleukin (IL)–
12p35//p40/ (), IL-12p40/ (), and IL-12p35/ () mice. Mice
were intraperitoneally infected with T. b. brucei trypanosomes35 10
and T. evansi trypanosomes, with a lower limit of detection of31 10
and parasites/mL, respectively, for infected mice. Data5 52.7 10 4 10
points are the mean values from 2–3 pooled experiments involving 10–
15 individual mice/group. J, Inferred data points appearing below the
limit of detection. The x-axis of panel B has been cropped from 100 days
to 65 days to show detail. At each time point, the statistical significance
between infected wild-type and IL-12–deficient mice was determined
using 1-way analysis of variance (Dunnett’s posttest). * ; **P ! .05 P !
..01
differences in parasitemia were observed between the different
IL-12–deficient strains.
In T. evansi infection, wild-type mice reduced their parasi-
temia at days 12, 23, and 36 after infection, forming several
waves of parasitemia, as opposed to all IL-12–deficient mice,
which failed to reduce their parasitemia (figure 1B). No sig-
nificant differences were observed between the IL-12–deficient
strains. In contrast to T. b. brucei infection, in which loss of
parasitemia control correlated with death among IL-12–defi-
cient mice, T. evansi infection was associated with a high par-
asite burden during infection in both wild-type and IL-12–
deficient strains.
Differential regulation of IFN-g and TNF by IL-12p70, de-
pending on the Trypanosoma species. IFN-g and TNF play
a role in resistance and parasitemia control [22, 29], with IL-
12 a known promoter of IFN-g production [30]. Plasma sam-
ples were obtained at the first parasitemia peak; at days 6 and
8 after infection with T. b. brucei and T. evansi, respectively;
and also after the second parasitemia peak, at days 20 and 28
after infection with T. b. brucei and T. evansi, respectively (figure
2). Both Trypanosoma species induced systemic IFN-g and TNF
production in wild-type mice, with there being a few days’ delay
associated with T. evansi infection. T. b. brucei infection in IL-
12–deficient mice resulted in a marked reduction in IFN-g
( ) and TNF ( ) production (figure 2A and 2B),P ! .05 P ! .01
compared with T. b. brucei infection in wild-type mice, with
similar residual low levels in all IL-12–deficient strains
observed.
In IL-12–deficient mice, T. evansi infection also resulted in
impaired IFN-g responses, compared with those seen in wild-
type controls, as was also seen in IL-12–deficient mice with T.
b. brucei infection (figure 2C). In contrast to T. b. brucei in-
fection, T. evansi infection in IL-12–deficient mouse strains
produced substantial amounts of TNF, with only a slight re-
duction observed (figure 2D).
Unimpaired IgG2a and IgM antibody titers in IL-12–de-
ficient mice, compared with wild-type mice, in response to
trypanosomiasis. Anti-VSG antibody responses are impor-
tant in parasitemia control and survival and, thus, were tested
in IL-12–deficient mice (figure 3). IgG2a levels were similar
between wild-type and IL-12–deficient mice at days 6 (figure
3A) and 20 (figure 3B) after infection with T. b. brucei. At either
the first parasitemia peak (figure 3C) or during chronic stages
of infection (figure 3D), IgM levels were similar in IL-12–de-
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Figure 2. Plasma levels of interferon (IFN)–g and tumor necrosis factor (TNF) measured in wild-type (black bars), interleukin (IL)–12p35//p40/
(white bars), IL-12p40/ (diagonally striped bars), and IL-12p35/ (hatched bars) mice infected with Trypanosoma brucei brucei (A and B), and
Trypanosoma evansi (C and D) by means of ELISA. Results are representative of findings from 2 independent experiments; however, TNF levels in IL-
12p40–deficient mice were not consistently significantly reduced. Data are expressed as mean values (SE) for 2–3 individual mice. Statistical
significance was determined using an unpaired Student’s t test. * ; ** .P ! .05 P ! .01
IFN-g production crucial for resistance to trypanosomiasis.
Reduced survival was observed among IFN-gR (129Sv/Ev)–
deficient mice, compared with wild-type (129Sv/Ev) mice, for
both Trypanosoma strains, with death occurring at a mean of
16 versus 41 days after T. b. brucei infection ( ) (figureP ! .001
4A) and at a mean of 15 versus 27 days after T. evansi infection
( ) (figure 4C), respectively. IFN-gR–deficient mice in-P ! .001
fected with T. b. brucei were unable to sufficiently clear the first
wave of parasitemia and died shortly thereafter (figure 4B), in
association with a 10-fold increase in parasitemia from day 9
after infection until death ( ), compared with the wild-P ! .05
type controls. The T. b. brucei results obtained in this study are
similar to those reported for Trypanosoma brucei rhodesiense–
infected C57BL/6 wild-type and C57BL/6 IFN-g–deficient mice
[22], indicating no major differences between the 129Sv/Ev and
C57BL/6 genetic backgrounds with regard to susceptibility due
to loss of IFN-g signalling. Interestingly, T. evansi infection
resulted in high parasitemia in both wild-type and IFN-gR–
deficient strains (figure 4D).
DISCUSSION
IL-12p35//p40/, IL-12p40/, and IL-12p35/ mouse
strains showed significantly reduced survival, compared with
wild-type controls, when infected with either T. b. brucei or T.
evansi. This outcome is in agreement with previous results
showing an association with lower IL-12p70 levels in susceptible
wild-type mice, compared with mice that were more resistant
to trypanosomiasis, during the initial stages of infection [22].
Between the 3 IL-12–deficient mouse strains, no differences in
survival rates were observed, suggesting that IL-12p70 is the
main protective factor for survival, with there being no major
contribution from other IL-12 family members—namely, IL-
23 or the IL-12p80 homodimer. IL-12–deficient mice survived
several waves of parasitemia; therefore, residual protection oc-
curs and may imply that IL-12 plays a more striking role during
established disease.
Because IFN-g is an important factor in survival, as was
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Figure 3. IgG2a and IgM plasma antibody titers of Trypanosoma brucei brucei–infected (at day 6 [A] and day 20 [B] after infection) and Trypanosoma
evansi–infected (at day 8 [C] and day 28 [D] after infection) C57BL/6 wild-type (), C57BL/6 interleukin (IL)–12p35/ (), C57BL/6 IL-12p40/ (),
and C57BL/6 IL-12p35/p40/ () mice. Preimmune plasma was used as a noninfected control (). Data points denote mean values (SE) for
plasma antibody titers from 2–3 individual mice.
we determined plasma levels of IFN-g during infection. In wild-
type mice, IFN-g was present during the first wave of parasi-
temia, with striking reductions in IFN-g levels observed in all
IL-12–deficient mouse strains. These results also demonstrate
that residual IL-12–independent IFN-g production is induced
during infection by both trypanosome strains. Therefore, the
observed, limited type-1 response allowed residual protective
immunity. IL-12–independent induction of IFN-g may also
include a direct stimulus by either trypanosome species. Try-
panosome-derived lymphocyte triggering factor has been found
to induce the production of IFN-g by binding to CD8+ cells
in T. b. brucei [31] and T. evansi [32] infections and, therefore,
may have contributed to residual resistance in the absence of
IL-12. In addition, work describing IL-12–independent IFN-g
production with residual Th1 responses has been demonstrated
by us and others during infections with Listeria monocytogenes
[19], Mycobacterium bacille Calmette-Gue´rin [16], and Leish-
mania major [20]. Furthermore, to evaluate the possible con-
tribution of IFN-g to resistance, IFN-gR–deficient mice were
infected; they died shortly after the first wave of parasitemia.
Although the IFN-gR–deficient mice used in the present study
were of a different genetic background than the IL-12–deficient
mice, the results are in line with the conclusions of Hertz et
al. [22], who studied IFN-g–deficient mice with a C57BL/6
background. These results clearly highlight the crucial impor-
tance of IFN-g responsiveness during acute infection with T.
b. brucei or T. evansi.
Although IL-12–deficient mice did have significantly reduced
rates of parasitemia clearance after the first peak, compared
with wild-type mice, the IL-12–deficient mice ultimately were
as effective in clearing the first peak as were the control mice.
IFN-g and TNF cytokine levels in all groups of IL-12–deficient
mice were significantly attenuated during the initial parasitemia
peak. Together with the observation of a drastically reduced
capacity to control parasitemia in infected IFN-gR– and TNF-
deficient mice [24] during this period, the low plasma con-
centrations of these 2 cytokines in IL-12–deficient mice are still
effective for initial parasitemia control. These results further
suggest that IL-12 plays a more dominant role in parasitemia
control after the second peak than during the initial parasitemia
peak, for optimal promotion of TNF and IFN-g production.
TNF has been found to have dual effects in T. b. brucei
infections, such as causing trypanolytic effects [29, 33], reduc-
ing the parasite burden in T. b. brucei AnTat 1.1 infections [24,
34, 35], and causing immunopathological effects in the host
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Figure 4. Survival and parasitemia profiles of 129Sv/Ev wild-type () and 129Sv/Ev interferon-g receptor (IFN-gR)–deficient () mice infected with
Trypanosoma brucei brucei (A and B) and Trypanosoma evansi (C and D). Mice were intraperitoneally infected with T. b. brucei trypanosomes35 10
(11 wild-type and 12 IFN-gR–deficient mice) and T. evansi trypanosomes (14 wild-type and 17 IFN-gR–deficient mice) per mouse. The limit31 10
of detection for T. b. brucei parasitemia and T. evansi parasitemia is and parasites/mL, respectively. Data on mortality and parasitemia5 64.4 10 1 10
were pooled from 2 independent experiments performed on 4–5 mice/group used for parasitemia measurement for either experiment. J, Inferred data
points appearing below the limit of detection. The Kaplan-Meier test was used for mortality, and the unpaired Student’s t test was used for parasitemia.
* .P ! .05
mice, no decrease in pathological findings was detected in
spleen and liver sections obtained from T. b. brucei– or T.
evansi–infected mice (data not shown). In addition, B cell re-
sponses are necessary for the elimination of vascular-bound
parasites; in particular, IgM and IgG2a are said to be the main
antibodies necessary for clearance of T. b. brucei infection (S.M.,
R.A.A., A. Schwegmann, M. Drennan, F. Claes, P. De Baetselier,
F.B., unpublished data) [4]. Both VSG-specific antibodies were
present in the plasma of IL-12–deficient mice, albeit in mod-
erately reduced levels, compared with wild-type mice; therefore,
they may not be the overall mechanism of increased parasite
burden. The role of IL-12 in T. b. brucei infection therefore
seems to be limited to the more chronic stage of disease and
the promotion of the TNF and IFN-g production necessary to
control parasitemia.
Natural killer cells, which are thought to be necessary for
resistance during initial infection, are activated by both IL-12
and IL-18 [36], and IL-18 thus may effectively drive the Th1
response in the absence of IL-12. Furthermore, in a recent study,
Drennan et al. [37] found that MyD88 signaling is crucial for
resistance and that there is a role for Toll-like receptor (TLR)
9 in this immune pathway. The TLR9- and IL-12–deficient mice
share many phenotypic characteristics in their response to T.
b. brucei infection, including (1) effective parasitemia control
during the first parasitemia peak but increased parasitemia dur-
ing the chronic stages of disease and (2) reduced IFN-g pro-
duction but normal IgG2a responses during the chronic stages
of disease, compared with those noted in wild-type mice. Bone
marrow–derived macrophages obtained from TLR9-deficient
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in response to T. b. brucei genomic DNA. Therefore, IL-12 may
be involved in the immunologic pathway, whereby TLR9 pres-
ent on macrophages responds to T. b. brucei genomic DNA
released after the first parasitemia peak and, on IL-12 secretion,
stimulates peripheral blood mononuclear cells (PBMCs) to se-
crete IFN-g. With the presence of TLR9 on B cells, a role for
IL-12 may also be considered. However, with only a slight
reduction in IgG2a responses during the chronic stages of dis-
ease, as reported in this article as well as in the study by Dren-
nan et al. [37], it is more likely that other factors play a more
significant role in proliferation and differentiation of these cells.
In contrast to IL-12–deficient mice, TLR9-deficient mice pro-
duce more IFN-g during the chronic stages of T. b. brucei
infection. Reduced IFN-g production may explain the increased
susceptibility in IL-12–deficient mice, compared with TLR9-
deficient mice, which showed resistance similar to that noted
among wild-type mice. The function of IL-12 may thus be to
associate TLR9 signaling in macrophages during the chronic
stages of T. b. brucei infection with the up-regulation of IFN-
g secretion in PBMCs necessary for effective parasitemia con-
trol and survival.
Parasitemia in wild-type mice infected with T. evansi differed
from that in wild-type mice infected with T. b. brucei. Wild-
type mice with T. evansi infection showed a severe inability to
efficiently clear waves of parasitemia, with this inability dete-
riorating after each successive wave and suggesting a progressive
erosion of immune control. IL-12–deficient mice infected with
T. evansi were unable to reduce parasitemia, compared with
wild-type mice. However, later during infection, no differences
between IL-12–deficient and wild-type mice were found. This
suggests a role for IL-12p70 signaling in early parasitemia con-
trol. During the initial and late time points examined, plasma
levels of IFN-g were severely reduced in IL-12–deficient mice,
compared with wild-type mice; however, in contrast to T. b.
brucei, plasma levels were only moderately lower for TNF in
IL-12–deficient mice. IFN-gR–deficient mice infected with T.
evansi were highly susceptible to trypanosomiasis, were unable
to clear the first parasitemia peak, and rapidly died thereafter.
This finding clearly demonstrates the importance of IFN-g,
although a direct comparison with IL-12–deficient mice is ham-
pered by the difference in the genetic background of the de-
ficient mouse strains and the mortality rate among wild-type
controls with T. evansi infection. TNF levels were not severely
reduced in IL-12–deficient mice and were found not to be
important in survival or parasitemia control [38]. In terms of
anti-VSG B cell responses, it recently has been shown that IgM
is crucial for parasitemia control and survival [38]. However,
we found no obvious differences between wild-type and IL-12–
deficient mouse strains. Therefore, the mechanism of impaired
parasitemia control in T. evansi infection is dependent on IL-
12, with a possible role for IFN-g, as has been found in T. b.
brucei infection.
A comparison between the results obtained by Baral et al.
[38] for the C57BL/6 IFN-g–deficient mice and the results
shown in the present article for the 129Sv/Ev IFN-gR–deficient
mice reveals opposing findings. This difference could be due
to the emergence of a more virulent strain in our experiments,
because the T. evansi parasites used are nonclonal field stabilates
and have been passaged for stock maintenance. In addition,
the specific pathogen–free conditions at our facilities may ex-
clude concurrent infections that may independently initiate an
IL-12–driven Th1 response necessary for optimal resistance.
These effects, although untested, add impetus for further in-
vestigation into the immunology of T. evansi.
In conclusion, the data presented in this article show that
IL-12p70—but not the IL-12p80 homodimer or IL-23—is nec-
essary for optimal resistance to T. evansi and T. b. brucei in-
fection, in terms of mortality and parasitemia control. The
resistance attributed to IL-12 is mediated through IFN-g, the
production of which was significantly decreased in the absence
of IL-12. Furthermore, a role for IL-12 in parasitemia control
during the chronic stage of T. b. brucei infection was shown,
in which the presence of IL-12 is needed for optimal TNF and
IFN-g production reducing the parasitemia burden.
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